TORONTO, March 12, 2025 (GLOBE NEWSWIRE) -- The courts have ruled on two cases impacting thousands of elderly hospital patients and long-term care residents in Ontario and the Ontario Health Coalition ...

(OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat viral diseases, unveiled a potential game-changer in the fight against Highly ...

SCOTTSDALE, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (Nasdaq: DERM), a commercial-stage pharmaceutical company that primarily focuses on selling and ...

TUCSON, Ariz., March 12, 2025 (GLOBE NEWSWIRE) -- Governments issue regulations with tremendous impact on the economy and on health practices. These regulations are based on published scientific ...

GENEVA, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- As extending healthy human lifespan evolves beyond theoretical possibility, Informa Connect pushes boundaries with the launch of its Global ...

Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro et les sciences de la vie, annonce aujourd'hui, 11 mars 2025, la signature d'un a ...

The integration enables seamless referrals for GI Care through Teladoc Health’s platform ...

At Genmab A/S’ Annual General Meeting held today March 12, 2025, the Annual Report for 2024 was approved Discharge was given to the Board of Directors and the Executive Management and the year’s ...

Shuttle Pharma intends to use the net proceeds from the Offering to fund Shuttle Pharma’s Phase II clinical trial for its lead product candidate, for marketing and advertising services, and for ...

These acquisitions will allow Eurobio Scientific to reinforce its operations in Italy and commercially integrate the distribution of its proprietary products. On an annual basis, Eurobio Scientific ...

Iolyx Therapeutics, a clinical-stage biotechnology company focused on the development of therapeutics at the intersection of ocular inflammation and autoimmunity, today announced acceptance of ...

To learn more, please visit www.reprievetrial.org.